SOLICITATION NOTICE
B -- RFI for Double-blind, randomized, placebo-controlled single- dose cross-over study to study the electrocardiographic effects of 4 different drugs in healthy subjects - RFI for Double-blind, randomized, placebo-controlled single- dose cross-over study to study the electrocardiographic effects of 4 different drugs in healthy subjects
- Notice Date
- 7/17/2012
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-RFI-12-1105122
- Archive Date
- 8/8/2012
- Point of Contact
- Tara R. Hobson, Phone: 3018279691, Doreen Williams, Phone: 3018273366
- E-Mail Address
-
Tara.Hobson@fda.hhs.gov, doreen.williams@hhs.fda.gov
(Tara.Hobson@fda.hhs.gov, doreen.williams@hhs.fda.gov)
- Small Business Set-Aside
- N/A
- Description
- RFI for Double-blind, randomized, placebo-controlled single- dose cross-over study to study the electrocardiographic effects of 4 different drugs in healthy subjects
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-RFI-12-1105122/listing.html)
- Record
- SN02805612-W 20120719/120717235942-1296b2d37a312f970b2084628fee3662 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |